KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

AbbVie (ABBV) EBT Margin (2016 - 2025)

AbbVie (ABBV) has disclosed EBT Margin for 14 consecutive years, with 16.05% as the latest value for Q4 2025.

  • Quarterly EBT Margin rose 3108.0% to 16.05% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 10.79% through Dec 2025, up 419.0% year-over-year, with the annual reading at 10.79% for FY2025, 419.0% up from the prior year.
  • EBT Margin for Q4 2025 was 16.05% at AbbVie, up from 4.53% in the prior quarter.
  • The five-year high for EBT Margin was 36.41% in Q1 2022, with the low at 15.02% in Q4 2024.
  • Average EBT Margin over 5 years is 15.15%, with a median of 14.33% recorded in 2024.
  • The sharpest move saw EBT Margin soared 3957bps in 2021, then tumbled -3252bps in 2023.
  • Over 5 years, EBT Margin stood at 28.69% in 2021, then crashed by -32bps to 19.61% in 2022, then crashed by -57bps to 8.47% in 2023, then crashed by -277bps to 15.02% in 2024, then skyrocketed by 207bps to 16.05% in 2025.
  • According to Business Quant data, EBT Margin over the past three periods came in at 16.05%, 4.53%, and 10.08% for Q4 2025, Q3 2025, and Q2 2025 respectively.